This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Kindred Healthcare Comments On Proposed 2012 Medicare Payment Rates For Skilled Nursing Facilities

Stocks in this article: KND RHB

Kindred Healthcare, Inc. (the “Company”) (NYSE:KND) today issued a response to the proposed rule issued late yesterday by the Centers for Medicare and Medicaid Services (“CMS”) regarding Medicare payment rates for skilled nursing facilities for fiscal year 2012.

“Kindred shares CMS’s goal that Medicare rates should support quality care for increasingly medically complex patients who also require intensive rehabilitation services in order to reduce lengths of stay, return patients home more quickly and reduce rehospitalizations,” said Paul J. Diaz, President and Chief Executive Officer of the Company. “The proposed rule offers two alternatives for a potential parity adjustment, one of which recognizes that three months’ worth of data may be insufficient to arrive at an accurate calculation of rates. Kindred strongly agrees with this approach and urges CMS to ensure that adequate data exists before arriving at definitive conclusions.”

“Specifically, Kindred has experienced a 4.2% decline in Medicare average length of stay from 2008-2010 and a 2.4% decline in the first quarter of 2011 compared to the same period last year. This not only validates our value proposition of transitioning patients home sooner, but also is relevant to an assessment of the extent of a parity adjustment since Medicare saves money with fewer patient days,” continued Mr. Diaz. “Accurate data is also necessary before developing a rational policy for group therapy. While it is appropriate for CMS to examine whether the use of group therapy is a factor in arriving at accurate rates, Kindred's data shows that only 11% of therapy hours are attributable to group therapy and by far individual therapy is the most common treatment modality at approximately 88%. Accordingly, we look forward to working with CMS and Congress to ensure that adequate and appropriate payment rates for the sector are based upon sufficient data analysis and enable us all to fulfill our collective goal of providing quality post-acute care for patients in the most cost-effective setting.”

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs